Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Belluscura PLC ( (GB:BELL) ) has shared an update.
Belluscura PLC is in ongoing discussions with the Omaha Investor Group regarding a revised refinancing proposal, though no funding has been secured yet. Meanwhile, Sallyport Commercial Finance has foreclosed on Belluscura LLC’s assets, excluding key intellectual property, and the company faces potential bankruptcy without the proposed refinancing.
More about Belluscura PLC
Belluscura PLC is a UK-based medical device company specializing in oxygen enrichment technology, serving various industries and therapeutic applications.
Technical Sentiment Signal: Strong Sell
Current Market Cap: £3.01M
For detailed information about BELL stock, go to TipRanks’ Stock Analysis page.